Companies seeking to transform innovative materials into products have a range of options, writes Matthew Cohen of venture-capital firm Pangaea Ventures
The Scottish photonics spin-out is ramping up pre-clinical trials and seeking investment for groundbreaking non-invasive cataract diagnosis and treatment